Literature DB >> 23623923

CD147 mediates chemoresistance in breast cancer via ABCG2 by affecting its cellular localization and dimerization.

Shuangyuan Zhou1, Liqiu Liao, Chen Chen, Weiqi Zeng, Shuang Liu, Juan Su, Shuang Zhao, Mingliang Chen, Yehong Kuang, Xiang Chen, Jie Li.   

Abstract

CD147 and ABCG2 both have been reported to mediate Multidrug resistance (MDR) in breast cancer. Recent study demonstrates that CD147 could form a complex with ABCG2 on the cell membrane in primary effusion lymphoma. However, whether these two molecules regulate each other in breast cancer and result in MDR is not clear. We established four MCF-7 cell lines transfected with CD147 and/or ABCG2 and found that CD147 could increase the expression and dimerization of ABCG2, affect its cellular localization and regulate its drug transporter function. The findings derived from cells were confirmed subsequently in clinic samples of chemotherapy-sensitive/resistant breast cancer.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ABCG2; Breast cancer; CD147; Chemoresistance

Mesh:

Substances:

Year:  2013        PMID: 23623923     DOI: 10.1016/j.canlet.2013.04.025

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity.

Authors:  Yehong Kuang; Shouman Wang; Lili Tang; Jian Hai; Guojiao Yan; Liqiu Liao
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

2.  Identification of an HLA-A2-restricted CD147 epitope that can induce specific CTL cytotoxicity against drug resistant MCF-7/Adr cells.

Authors:  Chuang Qu; Shuhui Gao; Hongwei Shao; Wenfeng Zhang; Huabben Bo; Xin Lu; Tianjiao Chen; Jing Kou; Yue Wang; Gui Si Chen; Shulin Huang; Han Shen
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

Review 3.  Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.

Authors:  Abudureyimu Tuerhong; Jin Xu; Si Shi; Zhen Tan; Qingcai Meng; Jie Hua; Jiang Liu; Bo Zhang; Wei Wang; Xianjun Yu; Chen Liang
Journal:  Cell Mol Life Sci       Date:  2021-06-15       Impact factor: 9.261

4.  PTTG promotes invasion in human breast cancer cell line by upregulating EMMPRIN via FAK/Akt/mTOR signaling.

Authors:  Hui Gao; Feng Zhong; Jing Xie; Jianjun Peng; Zhiwu Han
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

5.  Upregulation of S100A9 contributes to the acquired resistance to BRAF inhibitors.

Authors:  Sung-Hee Hwang; Jun-Ho Ahn; Michael Lee
Journal:  Genes Genomics       Date:  2019-08-06       Impact factor: 1.839

Review 6.  The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.

Authors:  Lijuan Xiong; Carl K Edwards; Lijun Zhou
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

7.  Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.

Authors:  Sara Granja; Ibtissam Marchiq; Renaud Le Floch; Conceição Souto Moura; Fátima Baltazar; Jacques Pouysségur
Journal:  Oncotarget       Date:  2015-03-30

8.  Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy.

Authors:  Bo Wu; Jian Cui; Xiang-Min Yang; Zhen-Yu Liu; Fei Song; Ling Li; Jian-Li Jiang; Zhi-Nan Chen
Journal:  Cell Death Dis       Date:  2017-07-13       Impact factor: 8.469

9.  Nuclear envelope-distributed CD147 interacts with and inhibits the transcriptional function of RING1 and promotes melanoma cell motility.

Authors:  Junchen Chen; Cong Peng; Li Lei; Jianglin Zhang; Weiqi Zeng; Xiang Chen
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

10.  Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.

Authors:  Xiuyun Tian; Chunxiang Ye; Yongyong Yang; Xiaoya Guan; Bin Dong; Min Zhao; Chunyi Hao
Journal:  J Transl Med       Date:  2015-10-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.